Back To TOP

Co-pay Cards Genentech BioOncology™ Co-pay Card

ZELBORAF Access Solutions offers the ZELBORAF Co-pay Card to help you with the out-of-pocket costs of your ZELBORAF® (vemurafenib) prescription.

activate card

 

 

Qualified Patients*

  • I am covered by commercial insurance
    • To answer "yes" to this question, you cannot be covered by a government-funded health care program such as Medicare, Medicaid, Medigap, VA, DoD or Tricare
  • I am age 18 years or older
  • I currently live or get treatment in the United States or Puerto Rico†

 

If you answered "yes" to all the questions above, you are eligible.

 

* If you are receiving funding from the Genentech® Access to Care Foundation, you are not eligible for the Genentech BioOncology Co-pay Card.
† Vermont state laws do not allow programs like this.

 

 

What the card covers

 

 

Need help with enrollment? Call (855) MYCOPAY/(855) 692-6729.

FAQs

 
Q:

What types of help do you offer when my plan asks for high co-pays?

 
A: 

If you have concerns about covering the cost of your co-pay, we can help. We can refer you to a co-pay foundation to assist you. It can help you cover the cost of the co-pay. We also offer a co-pay card program.

 
View All

Learn More About
ZELBORAF
  • LEARN about treatment with Zelboraf
  • LEARN HOW the Genentech BioOncology Co-pay Card can help with the out-of-pocket costs for ZELBORAF
  • Form Patient Authorization and Notice of Release of Information (Current Version)

Indication and Important Safety Information

This information does not take the place of talking to your doctor about your medical condition or your treatment with ZELBORAF.

ZELBORAF is a prescription medicine used to treat a type of skin cancer called melanoma, that has spread to other parts of the body or cannot be removed by surgery, and has a certain type of abnormal “BRAF” gene.

ZELBORAF may cause a type of skin cancer called cutaneous squamous cell carcinoma (cuSCC).  CuSCC usually does not spread to other parts of the body.  Check your skin and tell your doctor about skin changes including a new wart, a sore or bump that bleeds or does not heal, or a mole that changes size or color.

While taking ZELBORAF, you should avoid going out in the sun.  When you go outside, wear clothes that protect your skin, including head, face, hands, arms, and legs.  Use lip balm and a broad-spectrum sunscreen with SPF 30 or higher.

Possible serious side effects of ZELBORAF include severe allergic reactions, severe skin reactions, changes in the electrical activity of your heart called QT prolongation, which can potentially be life-threatening, abnormal liver function tests, eye problems, or new melanoma lesions.

Common side effects of ZELBORAF include joint pain, rash, hair loss, tiredness, sunburn or sun sensitivity, nausea, itching, or warts.

These are not all of the possible side effects of ZELBORAF.  Tell your doctor if you have any side effect that bothers you or does not go away.  For more information about side effects, ask your doctor or pharmacist.

Call your doctor for medical advice about any side effects.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.

Please see full Prescribing Information and Medication Guide for additional important safety information.